VETS: PTSD Gets No Benefit from Antipsychotic

The one major concern many have is that the reason the Rx fail veterans with PTSD is that the core cause is exposure to depleted uranium in the war zone.

Read more at our sister sites here and here...

Our organization has recently worked with some attorneys regarding this issue.

By Charles Bankhead, Staff Writer, MedPage Today

August 02, 2011

Military-related post-traumatic stress disorder (PTSD) showed no response to risperidone (Risperdal) for antidepressant-resistant symptoms, data from a multicenter Veterans Affairs study showed.

Risperidone-treated patients had about a four-point greater improvement on a PTSD scale than did those who received placebo, but the difference did not achieve statistical significance.

Detailed analysis showed no significant difference between groups at any point during the six months of follow-up, John H. Krystal, MD, of the VA Connecticut Healthcare System in West Haven, and co-authors reported in the Aug. 3 issue of JAMA. read more

from Natural Health News

Natural Health News: Closed Head Injury and PTSD

Sep 10, 2007

The major concerns behind this effort, even though the oldest vet we have helped is 85, are depleted uranium, PTSD and traumatic brain injury(TBI). I watched how little is done for the returning vets in a news story ...

Veterans, Psych Drugs, and Deaths

Recently reported in Marine Corps Times and other media venues including Preventive Psychiatry E-Newsletter, it has been noted that psychotropic drug-induced sudden deaths are increasing in Iraq War Veterans.

Most of the newer psych drugs are fluoride based and are known to have cardiac effects among the many problems they cause.

Other over looked problems may be from depleted uranium exposure.

If you suppress respiratory function enough you will impact heart function because of low oxygen levels. Old studies showed that low O2 levels in the blood caused more deaths at 4 AM and that often there was evidence of cardiac arrythmia.

Read complete article

Interactions: Combined Seroquel, Klonopin, Paxil
clonazepam ↔ paroxetine
Applies to: Klonopin (clonazepam), Paxil (paroxetine)

MONITOR: Central nervous system- and/or respiratory-depressant effects may be additively or synergistically increased in patients taking multiple drugs that cause these effects, especially in elderly or debilitated patients.

clonazepam ↔ quetiapine
Applies to: Klonopin (clonazepam), Seroquel (quetiapine)

MONITOR: Central nervous system- and/or respiratory-depressant effects may be additively or synergistically increased in patients taking multiple drugs that cause these effects, especially in elderly or debilitated patients.

paroxetine ↔ quetiapine
Applies to: Paxil (paroxetine), Seroquel (quetiapine)

MONITOR: Central nervous system- and/or respiratory-depressant effects may be additively or synergistically increased in patients taking multiple drugs that cause these effects, especially in elderly or debilitated patients.

MANAGEMENT: During concomitant use of these three drugs, patients should be monitored for potentially excessive or prolonged CNS and respiratory depression . Ambulatory patients should be counseled to avoid hazardous activities requiring mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.